DNTH position history
The shares of Dianthus Therapeutics (DNTH) that POLEN CAPITAL MANAGEMENT LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q1: 4,119 shares, $346K, <0.01% of portfolio, New
- 2026 Q2: 9,333 shares, $910K, <0.01% of portfolio, Add +126.6%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|